Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis

被引：0
|
作者：
Phyllis Chan
Jiajie Yu
Leslie Chinn
Marita Prohn
Jan Huisman
Brett Matzuka
William Hanley
Katie Tuckwell
Angelica Quartino
机构：
[1] Clinical Pharmacology,Clinical Sciences
[2] qPharmetra,undefined
[3] qPharmetra,undefined
[4] Former Genentech employee,undefined
[5] currently of Seattle Genetics,undefined
[6] Early Clinical Development,undefined
来源：
Pharmaceutical Research | 2020年 / 37卷 / 2期
关键词：
Bruton’s tyrosine kinase (BTK) inhibitor; exposure-response; model-based meta-analysis; population pharmacokinetics; rheumatoid arthritis;
D O I：
10.1007/s11095-019-2752-y
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial
    Goss, Sandra L.
    Klein, Cheri E.
    Jin, Ziyi
    Locke, Charles S.
    Rodila, Ramona C.
    Kupper, Hartmut
    Burmester, Gerd-Rudiger
    Awni, Walid M.
    CLINICAL THERAPEUTICS, 2018, 40 (02) : 309 - 319
  • [22] Exposure-Response Modeling and Simulation of the Efficacy Endpoints in Rheumatoid Arthritis
    Ma, Lian
    Ji, Ping
    Wang, Yaning
    Zhao, Liang
    Xu, Yun
    Doddapaneni, Suresh
    Sahajwalla, Chandrahas G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S73 - S73
  • [23] Efficacy of Biologicals in the Treatment of Rheumatoid Arthritis A Meta-Analysis
    Venkateshan, S. P.
    Sidhu, S.
    Malhotra, S.
    Pandhi, P.
    PHARMACOLOGY, 2009, 83 (01) : 1 - 9
  • [24] Risk of epilepsy in rheumatoid arthritis: a meta-analysis of population based studies and bioinformatics analysis
    Zhao, Huawei
    Li, Shan
    Xie, Meijuan
    Chen, Rongrong
    Lu, Haimei
    Wen, Chengping
    Filiano, Anthony J.
    Xu, Zhenghao
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2020, 11
  • [25] Population Pharmacokinetics and Exposure-Response Analyses for Abatacept in Juvenile Idiopathic Arthritis
    Li, X.
    Passarell, J. A.
    Lin, K.
    Roy, A.
    Murthy, B.
    Girgis, I. G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S127 - S128
  • [26] Exposure-Response Modeling and Power Analysis of ACR Core Components in Rheumatoid Arthritis
    Zhang, Yi
    Ma, Lian
    Ji, Ping
    Yim, Sarah
    Doddapaneni, Suresh
    Liu, Jiang
    Dinko, Rekic
    Brar, Satjit
    Wang, Yaning
    Sahajwalla, Chandrahas
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S68 - S68
  • [27] Model-Based Exposure-Response Analysis of Apixaban to Quantify Bleeding Risk in Special Populations of Subjects Undergoing Orthopedic Surgery
    Leil, Ta
    Frost, C.
    Wang, X.
    Pfister, M.
    LaCreta, F.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2014, 3 (09):
  • [28] Population Approach for Exposure-Response Modeling of Golimumab in Patients With Rheumatoid Arthritis
    Hu, Chuanpu
    Xu, Zhenhua
    Zhang, Yi
    Rahman, Mahboob U.
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 639 - 648
  • [29] Population Pharmacokinetics of Oral Azacitidine, and Exposure-Response Analysis in Acute Myeloid Leukemia
    Gaudy, Allison
    Laille, Eric
    Bailey, Rochelle
    Zhou, Simon
    Skikne, Barry
    Beach, C. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (04) : 845 - 852
  • [30] Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis
    Gewitz, Andrew D.
    Solans, Belen P.
    Mac Kenzie, William R.
    Heilig, Chad
    Whitworth, William C.
    Johnson, John L.
    Nsubuga, Pheona
    Dorman, Susan
    Weiner, Marc
    Savic, Radojka M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
12345